Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

Clinical trial NCT07358195 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07358195
Sponsor: Massachusetts General Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Kidney Failure Chronic Stem Cell Transplant Stem Cell Transplant Complications Tolerance Hematologic Cancer

Start date: 2026-07-01
Primary completion: 2028-12-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.